Page 93 - CIBEREHD2016-ENG
P. 93
Most relevant scientific articles
• Villanueva C., Albillos A., Genesca J., Abraldes J.G., Calleja J.L., Aracil C. et al. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension. Hepatology. 2016;63(1):197-206.
• Poca M., Alvarado-Tapias E., Concepcion M., Perez-Cameo C., Canete N., Gich I. et al. Predictive model of mortality in patients with spontaneous bacterial peritonitis. Alimentary Pharmacology and Therapeutics. 2016;44(6):629-637.
• Abraldes JG, Villanueva C, Aracil C, Turnes J, Hernandez-Guerra M, Genesca J et al. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.Gastroenterology. 2016;150(5).
• Berzigotti A, Albillos A, Villanueva C, Genescá J, Ardevol A, Augustín S et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The sportdiet study.Hepatology (Baltimore, Md.). 2016.
• Santiago A., Pozuelo M., Poca M., Gely C., Nieto J.C., Torras X. et al. Alteration of the serum microbiome composition in cirrhotic patients with ascites. Scientific Reports. 2016;6.
Hightlights
PROJECTS
• Study of the fragility syndrome in patients with hepatic cirrhosis. Relationship with cognitive impairment and quality of life.
• Treatment of hepatorenal syndrome with terlipressin associated with hemodynamic response.
• Study of the effect of VSL#3 on cognitive function, risk of falls and quality of life in patients with cirrhosis.
• Albumin administration in the prevention of hepatorenal syndrome and death in patients with cirrhosis,
bacterial infections other than spontaneous bacterial peritonitis and high risk of hospital mortality.
• Study of the alterations of the intestinal barrier in patients and experimental models of cirrhosis.
• Composition of the microbiota of gallbladder bile in an experimental model in C57BL / 6 mouse and
study the effect of different diets.
EHD
research Groups 93


































































































   91   92   93   94   95